Magnetic resonance imaging based rectal cancer classification: Landmarks and technical standardization

Table 2 Middle rectal cancer data

Age (yr)	Sex	CCRT	CM	R	L	Pre OP TS	TNM	O/L/R	OP	Post OP TS	TNM
64	F	N	7.0	Rb	2	II	T3N0	O	LAR	II	PT3N0
68	F	N	7.0	Rb	2	III	T3N+	O	LAR	II	PT3N0
50	M	Y	7.2	Rb	2	III	T3N+	L	LAR	III	YPT3N2
85	M	Y	7.8	Rb	2	III	T3N+	R	LAR	III	YPT3N1
66	M	N	8.0	Rb	2	III	T3N+	O	LAR	III	PT3N1
73	M	N	8.0	Rb	2	III	T3N+	L	LAR	III	PT3N1
49	M	Y	8.5	Rb	2	III	T3N+	R	LAR	0	YPT0N0
58	M	Y	8.8	Rb	2	III	T3N0	L	LAR	II	YPT3N0
78	M	N	9.0	Rb	2	II	T3N0	L	LAR	III	PT4N1
52	F	N	9.3	Rb	2	III	T3N+	R	LAR	III	PT3N2
61	F	Y	9.5	Rb	2	II	T3N0	L	LAR	III	YPT3N1
73	F	Y	9.5	Rb	2	III	T3N+	R	LAR	II	YPT3N0
48	M	Y	10.0	Rb	2	I	T2N0	R	LAR	I	YPT2N0
74	F	Y	10.0	Rb	2	III	T2N+	R	LAR	II	YPT3N0
47	F	N	10.0	Rb	2	III	T3N+	O	LAR	III	PT3N2
82	M	N	10.0	Rb	2	II	T3N0	L	LAR	II	PT3N0

CCRT: Concurrent chemoradition therapy; R: Rectal Japanese class; L: Level class; OP: Operative; TS: Tumor stage; TNM: Tumor, lymph node, metastasis; O/L/R: Open/laparoscopic, robotic), only M0 tumors were included; LAR: lower anterior resection.